Mosaic ImmunoEngineering, Inc. (OTCMKTS:CPMV – Get Free Report) traded down 49.8% on Friday . The stock traded as low as $0.30 and last traded at $0.30. 197 shares were traded during trading, a decline of 83% from the average session volume of 1,192 shares. The stock had previously closed at $0.60.
Mosaic ImmunoEngineering Price Performance
The firm’s fifty day moving average price is $0.49 and its two-hundred day moving average price is $0.50. The stock has a market cap of $2.17 million, a price-to-earnings ratio of -2.31 and a beta of -0.02.
Mosaic ImmunoEngineering (OTCMKTS:CPMV – Get Free Report) last announced its quarterly earnings data on Tuesday, May 14th. The company reported ($0.04) earnings per share for the quarter.
About Mosaic ImmunoEngineering
Mosaic ImmunoEngineering, Inc, a development-stage biotechnology company, focuses on developing and commercializing immunomodulator platform technology for the treatment of cancer and infectious diseases in humans and for veterinary use. Its lead immunotherapy product candidate, MIE-101, a nanoparticle-based treatment derived from cowpea mosaic virus, which is non-infectious in humans and animals.
See Also
- Five stocks we like better than Mosaic ImmunoEngineering
- Investing in Construction Stocks
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Learn Technical Analysis Skills to Master the Stock Market
- This Financial Stock’s Earnings Signal a Buying Opportunity
- How to Start Investing in Real Estate
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Mosaic ImmunoEngineering Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mosaic ImmunoEngineering and related companies with MarketBeat.com's FREE daily email newsletter.
